These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1533174)
1. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial. Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174 [TBL] [Abstract][Full Text] [Related]
2. Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase. Smith DC; Gerson SL; Liu L; Donnelly S; Day R; Trump DL; Kirkwood JM Clin Cancer Res; 1996 Jul; 2(7):1129-34. PubMed ID: 9816278 [TBL] [Abstract][Full Text] [Related]
3. Modulation of human lymphocyte O6-alkylguanine-DNA alkyltransferase by streptozotocin in vivo. Gerson SL Cancer Res; 1989 Jun; 49(11):3134-8. PubMed ID: 2524250 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. Friedman HS; Dolan ME; Moschel RC; Pegg AE; Felker GM; Rich J; Bigner DD; Schold SC J Natl Cancer Inst; 1992 Dec; 84(24):1926-31. PubMed ID: 1334154 [TBL] [Abstract][Full Text] [Related]
5. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities. Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841 [TBL] [Abstract][Full Text] [Related]
6. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. Marathi UK; Dolan ME; Erickson LC Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784 [TBL] [Abstract][Full Text] [Related]
7. Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancers. Willson JK; Haaga JR; Trey JE; Stellato TA; Gordon NH; Gerson SL J Clin Oncol; 1995 Sep; 13(9):2301-8. PubMed ID: 7666087 [TBL] [Abstract][Full Text] [Related]
8. Comparisons between sensitive and resistant human tumor cell lines regarding effects of polyamine depletion on chloroethylnitrosourea efficacy. Seidenfeld J; Sprague WS Cancer Res; 1990 Feb; 50(3):521-6. PubMed ID: 2137022 [TBL] [Abstract][Full Text] [Related]
9. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea]. Tokuda K Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592 [TBL] [Abstract][Full Text] [Related]
10. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU. Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853 [TBL] [Abstract][Full Text] [Related]
11. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Souliotis VL; Kaila S; Boussiotis VA; Pangalis GA; Kyrtopoulos SA Cancer Res; 1990 May; 50(9):2759-64. PubMed ID: 2328502 [TBL] [Abstract][Full Text] [Related]
12. N-Methyl-N-nitrosourea potentiation of cytogenetic damage induced by 1,3-bis(2-chloroethyl)-1-nitrosourea in normal human lymphocytes. Wiencke JK; Bodell WJ Cancer Res; 1985 Oct; 45(10):4798-803. PubMed ID: 4027969 [TBL] [Abstract][Full Text] [Related]
13. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761 [TBL] [Abstract][Full Text] [Related]
14. The role of O6-alkylguanine DNA alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytes. Trey JE; Gerson SL Cancer Res; 1989 Apr; 49(8):1899-903. PubMed ID: 2702633 [TBL] [Abstract][Full Text] [Related]
15. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer. Micetich KC; Futscher B; Koch D; Fisher RI; Erickson LC J Natl Cancer Inst; 1992 Feb; 84(4):256-60. PubMed ID: 1531148 [TBL] [Abstract][Full Text] [Related]
16. Effects of streptozotocin/bis-chloroethylnitrosourea combination therapy on O6-methylguanine DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro. Pieper RO; Futscher BW; Dong Q; Erickson LC Cancer Res; 1991 Mar; 51(6):1581-5. PubMed ID: 1825618 [TBL] [Abstract][Full Text] [Related]
17. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771 [TBL] [Abstract][Full Text] [Related]
18. Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro. Marathi UK; Kroes RA; Dolan ME; Erickson LC Cancer Res; 1993 Sep; 53(18):4281-6. PubMed ID: 8364924 [TBL] [Abstract][Full Text] [Related]
19. Tumour levels of O6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts. Tagliabue G; Citti L; Massazza G; Damia G; Giavazzi R; D'Incalci M Anticancer Res; 1992; 12(6B):2123-5. PubMed ID: 1295458 [TBL] [Abstract][Full Text] [Related]
20. Modulation of O6-alkylguanine-DNA alkyltransferase in rats following intravenous administration of O6-methylguanine. Dexter EU; Yamashita TS; Donovan C; Gerson SL Cancer Res; 1989 Jul; 49(13):3520-4. PubMed ID: 2731174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]